For BioSpace’s recent Ideal Employer report, life sciences professionals weighed in on the topic.

A research team may have discovered a means to prevent breast cancer from spreading to other parts of the body through the blocking of a single enzyme.

The agency found that more than 2.8 million antibiotic-resistant infections occurred in the U.S. each year, killing more than 35,000 people.

Companies from across the globe provide updates on their business and pipelines.

The European Commission approved the world’s first Ebola vaccine. The vaccine is manufactured by Merck and has a trade name of Ervebo.

The letter outlines multiple failures, including failure to have adequate written procedures for the receipt, identification and handling of raw materials and failure to adequately clean equipment and utensils.

Unfortunately, you’re not going to get along with everyone. But when you figure out how to communicate and both know what to expect, it goes a long way in smoothing out what could be a rocky ride.

In the last article on our series of common biopharma careers, we take a close look at what it takes to become a successful computer and information research scientist.

The advisory committee voted 14 to 2 that the benefits of the drug did not outweigh the risks to support approval. The FDA is not obligated to follow the recommendation, but typically do.

Merz, a global, diversified healthcare company, has announced plans for a new business structure that will enable the company to better address customer and patient needs, shorten innovation cycles and capitalize on new market opportunities.

HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pronounced 'viǝ-trīs).

The company will discontinue development of its lead T-cell asset, ATIR101, halt its ongoing Phase III trial and lay off half its staff.

Merck plunked down $576 million to acquire San Diego-based Calporta to gain access to preclinical TRPML1 agonists that are seen as potential treatments for neurodegenerative disorders such as Alzheimer’s or Parkinson’s.

Unfortunately, this makes Amgen yet another major biopharma company to exit or slim down work on neurological diseases. Others include Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and AstraZeneca.

Biomedical engineers at the University of Southern California developed a method using ultrasound to control and track drug release.

HES is a rare group of inflammatory disorders that affects approximately 20,000 people around the world.

The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift.

“Why should we hire you?” is a question frequently asked in job interviews, but what’s really behind the question, and how should you respond to it?

DNA is structurally suited to storing information for extended periods of time, given its half-life of 521 years.

Of the 40+ hours you spend at your desk or in your office each week, how many are actually spent being productive?